Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Drug Resistance
Wyeth cites study on reduced antibiotic-resistant pneumococcal disease since Prevnar launch
May 10th, 2006
Antibiotic resistance is a worldwide public health issue. Physicians around the world face an increasing clinical challenge as many life-threatening bacterial infections, once responsive to therapy, are building resistance to the most commonly prescribed antibiotic treatments. However, preventing the occurrence of disease through vaccination may help alleviate the challenges of antibiotic resistance, according to information from Wyeth Pharmaceuticals, maker of Prevnar. A study published in the New England Journal of Medicine (NEJM), "Effect of Introduction of the Pneumococcal Conjugate Vaccine on Drug-Resistant Streptococcus pneumoniae," has...
Source: Vaccine Weekly (2006-05-10)
|
